Yu Junwen, Liu Xiaoning, Zhu Zheng, Yang Zhongfang, He Jiamin, Zhang Lin, Lu Hongzhou
School of Nursing, Fudan University, Shanghai, China.
Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Guangdong, China.
Front Cardiovasc Med. 2023 Mar 23;10:1138234. doi: 10.3389/fcvm.2023.1138234. eCollection 2023.
HIV continues to be a major global health issue. The relative risk of cardiovascular disease (CVD) among people living with HIV (PLWH) was 2.16 compared to non-HIV-infections. The prediction of CVD is becoming an important issue in current HIV management. However, there is no consensus on optional CVD risk models for PLWH. Therefore, we aimed to systematically summarize and compare prediction models for CVD risk among PLWH.
Longitudinal studies that developed or validated prediction models for CVD risk among PLWH were systematically searched. Five databases were searched up to January 2022. The quality of the included articles was evaluated by using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). We applied meta-analysis to pool the logit-transformed C-statistics for discrimination performance.
Thirteen articles describing 17 models were included. All the included studies had a high risk of bias. In the meta-analysis, the pooled estimated C-statistic was 0.76 (95% CI: 0.72-0.81, = 84.8%) for the Data collection on Adverse Effects of Anti-HIV Drugs Study risk equation (D:A:D) (2010), 0.75 (95% CI: 0.70-0.79, = 82.4%) for the D:A:D (2010) 10-year risk version, 0.77 (95% CI: 0.74-0.80, = 82.2%) for the full D:A:D (2016) model, 0.74 (95% CI: 0.68-0.79, = 86.2%) for the reduced D:A:D (2016) model, 0.71 (95% CI: 0.61-0.79, = 87.9%) for the Framingham Risk Score (FRS) for coronary heart disease (CHD) (1998), 0.74 (95% CI: 0.70-0.78, = 87.8%) for the FRS CVD model (2008), 0.72 (95% CI: 0.67-0.76, = 75.0%) for the pooled cohort equations of the American Heart Society/ American score (PCE), and 0.67 (95% CI: 0.56-0.77, = 51.3%) for the Systematic COronary Risk Evaluation (SCORE). In the subgroup analysis, the discrimination of PCE was significantly better in the group aged ≤40 years than in the group aged 40-45 years (= 0.024) and the group aged ≥45 years (= 0.010). No models were developed or validated in Sub-Saharan Africa and the Asia region.
The full D:A:D (2016) model performed the best in terms of discrimination, followed by the D:A:D (2010) and PCE. However, there were no significant differences between any of the model pairings. Specific CVD risk models for older PLWH and for PLWH in Sub-Saharan Africa and the Asia region should be established. PROSPERO CRD42022322024.
艾滋病病毒(HIV)仍然是一个重大的全球健康问题。与未感染HIV的人相比,HIV感染者(PLWH)患心血管疾病(CVD)的相对风险为2.16。在当前的HIV管理中,CVD的预测正成为一个重要问题。然而,对于PLWH的最佳CVD风险模型尚无共识。因此,我们旨在系统地总结和比较PLWH中CVD风险的预测模型。
系统检索了针对PLWH中CVD风险建立或验证预测模型的纵向研究。截至2022年1月,检索了五个数据库。使用预测模型偏倚风险评估工具(PROBAST)评估纳入文章的质量。我们应用荟萃分析来汇总经对数转换的C统计量,以评估区分性能。
纳入了13篇描述17种模型的文章。所有纳入研究都有较高的偏倚风险。在荟萃分析中,抗HIV药物不良事件数据收集研究风险方程(D:A:D)(2010年)的汇总估计C统计量为0.76(95%CI:0.72 - 0.81,I² = 84.8%),D:A:D(2010年)10年风险版本为0.75(95%CI:0.70 - 0.79,I² = 82.4%),完整的D:A:D(2016年)模型为0.77(95%CI:0.74 - 0.80,I² = 82.2%),简化的D:A:D(2016年)模型为0.74(95%CI:0.68 - 0.79,I² = 86.2%),冠心病(CHD)的弗明汉风险评分(FRS)(1998年)为0.71(95%CI:0.61 - 0.79,I² = 87.9%),FRS CVD模型(2008年)为0.74(95%CI:0.70 - 0.78,I² = 87.8%),美国心脏协会/美国评分(PCE)的汇总队列方程为0.72(95%CI:0.67 - 0.76,I² = 75.0%),系统性冠状动脉风险评估(SCORE)为0.67(95%CI:0.56 - 0.77,I² = 51.3%)。在亚组分析中,PCE在年龄≤40岁的组中的区分度明显优于年龄在40 - 45岁的组(P = 0.024)和年龄≥45岁的组(P = 0.010)。撒哈拉以南非洲和亚洲地区没有开发或验证任何模型。
完整的D:A:D(2016年)模型在区分度方面表现最佳,其次是D:A:D(2010年)和PCE。然而,任何模型配对之间均无显著差异。应建立针对老年PLWH以及撒哈拉以南非洲和亚洲地区PLWH的特定CVD风险模型。国际前瞻性系统评价注册库编号:CRD42022322024。